British Journal of Hospital Medicine, Vol. 73, Iss. 9, 12 Sep 2012, pp 498 - 501
New agents have been introduced for the prevention of inappropriate thrombosis in the vascular tree and the heart. This article reviews, compares and contrasts the newer agents which inhibit activated factor X (Xa) or activated factor II (thrombin).
To view this article
You cannot access this article because you do not have a valid subscription. Please use the options below to create a subscription. If you have any queries about your account please contact our subscriptions department or telephone free 0800 137201 (UK callers only) or +44 (0)1722 716997 for callers outside the UK.